4.8 Article

Fabrication of Sealed Nanostraw Microdevices for Oral Drug Delivery

期刊

ACS NANO
卷 10, 期 6, 页码 5873-5881

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.6b00809

关键词

microdevices; nanobiotechnology; nanostraws; nanowires; oral drug delivery

资金

  1. NIH [5T32GM007175-37, ST32DK007762-38, R0IEB018842]
  2. ARCS
  3. U.S. Department of Commerce, National Institute of Standards and Technology [70NANB15H192]
  4. NSF [DGE-1106400, DGE-114747]
  5. NDSEG
  6. NSF-MRI [0821619]
  7. NSF -EAR [0949176]

向作者/读者索取更多资源

The oral route is preferred for systemic drug administration and provides direct access to diseased tissue of the gastrointestinal (GI) tract. However, many drugs have poor absorption upon oral administration due to damaging enzymatic and pH conditions, mucus and cellular permeation barriers, and limited time for drug dissolution. To overcome these limitations and enhance oral drug absorption, micron-scale devices with planar, asymmetric geometries, termed microdevices, have been designed to adhere to the lining of the GI tract and release drug at high concentrations directly toward GI epithelium. Here we seal microdevices with nanostraw membranes-porous nano structured biomolecule delivery substrates-to enhance the properties of these devices. We demonstrate that the nanostraws facilitate facile drug loading and tunable drug release, limit the influx of external molecules into the sealed drug reservoir, and increase the adhesion of devices to epithelial tissue. These findings highlight the potential of nanostraw microdevices to enhance the oral absorption of a wide range of therapeutics by binding to the lining of the GI tract, providing prolonged and proximal drug release, and reducing the exposure of their payload to drug-degrading biomolecules.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据